Analysts’ Viewpoint
Rise in incidence of lung cancer across the globe is driving the need for surgical operations. According to the WHO, around 2.21 million lung cancer cases were recorded worldwide in 2020. New developments in surgical technologies, such as minimally invasive surgical techniques, are making lung cancer surgeries safer, more efficient, and less traumatic. The global market is expanding as a result of increased patient demand for care in the early stages of the disease, when surgical intervention is most successful.
Growth in adoption of customized medicines and introduction of cutting-edge cancer therapies, such as immunotherapy, are likely to contribute to lung cancer surgery market development. The market for lung cancer surgery is primarily influenced by the availability of reimbursement policies and rise in accessibility of advanced medical technologies.
Lung cancer can be treated through various methods, including surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, or a combination of these approaches. The surgical procedure a patient undergoes is contingent on multiple considerations, such as the position and size of the tumor, patient's general well-being, and progression of the cancer.
Minimally invasive surgical techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic surgery, have revolutionized lung cancer surgery, making it less traumatic and more effective. These advanced surgical methods have reduced surgical time, improved patient outcomes, and reduced hospital stay.
Recovery times for surgeries performed via thoracotomy tend to be longer compared to minimally invasive VATS and robot-assisted procedures. Furthermore, wedge resection is performed in patients when reduced lung function does not allow them to undergo a lobectomy.
As per the lung cancer surgery market research report, lung cancer is one of the most common types of cancer. Incidence of the disease has been rising across the globe due to a number of factors such as smoking, air pollution, and exposure to radon gas. This is boosting the demand for its treatment, including surgical intervention.
Early detection along with availability of treatment for lung cancer is crucial in increasing survival rate and improving patient outcomes. As a result, lung cancer surgeries are becoming more prevalent, leading to a growth in the lung cancer surgery business. Rise in prevalence of lung cancer has led to an increase in R&D activities in the field, thus resulting in the development of more advanced surgical techniques and equipment. This is positively impacting the lung cancer surgery market value.
According to the lung cancer surgery market analysis report, advances in surgical techniques are expected to drive the industry in the near future. Technological advancements and emergence of new surgical techniques, such as minimally invasive procedures, have significantly reduced surgical invasiveness. These new techniques offer less pain, fewer complications, and improved results compared to traditional open surgeries. This has led to an increase in demand for these procedures, thus contributing to lung cancer surgery market growth.
Development of new and advanced surgical equipment, such as robotic systems and 3D-printed models, has also improved the precision and accuracy of lung cancer surgeries. For instance, minimally invasive procedures such as video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracic surgery have reduced the invasiveness of lung cancer surgeries and led to faster recovery times. This has further increased the success rate of these procedures.
In terms of procedure, the global market has been classified into lobectomy, segmentectomy, wedge resection, and pneumonectomy. The lobectomy segment held dominant share in 2022. The procedure is chosen for its high success rate in removing cancerous tissues and the minimal impact it has on lung function. As a result, it has become the standard of care for the treatment of early-stage lung cancer. Thus, the lobectomy segment is anticipated to maintain its dominant position in the next few years.
Advent of minimally invasive techniques, such as video-assisted thoracoscopic technique, has made lobectomy a less invasive option, thus increasing its popularity among patients and healthcare providers. The procedure is also well tolerated by patients, due to the low risk of complications and relatively quick recovery time. Thus, rise in demand for lobectomy procedures among lung cancer patients is fueling lung cancer surgery industry growth.
Based on approach, the global market has been divided into thoracotomy and minimally invasive surgery. Rise in adoption of minimally invasive procedures is likely to boost lung cancer surgery market demand during the forecast period.
Smaller incision and less invasive nature of these procedures result in less pain for patients and a faster recovery time. Patients are able to return to their normal activities sooner and experience less discomfort during the healing process.
Minimally invasive surgery has reduced the risk of postoperative complications. There is less risk of infection and wound complication since the incisions are smaller. Additionally, blood loss is often significantly less with minimally invasive procedures. This reduces the need for blood transfusions. Development of specialized instruments and techniques has allowed surgeons to perform complex procedures with greater precision and control.
According to the lung cancer surgery market report, the hospitals end-user segment is anticipated to account for major share during the forecast period. Hospitals are equipped with specialized resources, such as advanced medical equipment and highly skilled medical personnel, that are essential for the successful treatment of lung cancer. Hospitals have teams of specialists who are trained in the latest surgical techniques and technologies, which increases the likelihood of a positive outcome for patients.
Hospitals provide a centralized and comprehensive care system that offers a range of diagnostic and treatment options under one roof. This makes it easier for patients to access the care they need, as they do not have to navigate multiple providers and locations. Hospitals also provide a full range of support services such as rehabilitation and postoperative care. This can significantly improve patient outcomes.
According to the lung cancer surgery market analysis report, North America is projected to dominate the global landscape during the forecast period. High incidence of lung cancer in the region is driving the demand for its treatment.
According to the American Cancer Society, 234,030 new cases of lung cancer were diagnosed in the U.S. and around 144,000 people died from the disease in 2021. Increase in awareness about minimally invasive treatment is further driving lung cancer surgery market dynamics in the region.
Lung cancer surgery market share of North America is anticipated to increase further during the forecast period, owing to the rise in geriatric population in the region. Older individuals are more susceptible to lung cancer, leading to an increase in demand for its treatment.
The prevalence rate for lung cancer is high in Europe. It is the second most frequently diagnosed cancer in men, following prostate cancer, and the third most frequently diagnosed cancer in women, after breast and colorectal cancers.
Asia Pacific has a large population of smokers, which increases the risk of lung cancer. The region recorded 1,315,136 new cases of lung cancer in 2020, leading to high demand for surgical procedures. Additionally, increase in awareness about early diagnosis and treatment for lung cancer has led to a rise in demand for surgical procedures in the region.
The global industry is fragmented, with the presence of a large numbers of key players. Some of the prominent market players are Medtronic, Siemens Healthineers, Accuray Incorporated, KARL STORZ, Olympus Corporation, Intuitive Surgical, and Ethicon (Johnson & Johnson Services, Inc.).
Each of these players has been profiled in the global lung cancer surgery market forecast report based on parameters such as product portfolio, business segments, recent developments, company overview, and business strategies.
|
Attribute |
Detail |
|
Size in 2022 |
US$ 12.3 Bn |
|
Forecast Value in 2031 |
More than US$ 20.2 Bn |
|
CAGR |
5.6% |
|
Forecast Period |
2023–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
.Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
It was valued at US$ 12.3 Bn in 2022
It is projected to reach more than US$ 20.2 Bn by 2031
The CAGR is anticipated to be 5.6% from 2023 to 2031
Based on approach, the minimally invasive surgery segment held more than 60.0% share in 2022
North America is expected to account for the largest share from 2023 to 2031
Medtronic, Siemens Healthineers, Accuray Incorporated, KARL STORZ, Olympus Corporation, Intuitive Surgical, and Ethicon (Johnson & Johnson Services, Inc.)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Lung Cancer Surgery Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Lung Cancer Surgery Market Analysis and Forecasts, 2017 - 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Covid-19 Impact Analysis
6. Global Lung Cancer Surgery Market Analysis and Forecasts, By Procedure
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Procedure, 2017 - 2031
6.3.1. Lobectomy
6.3.2. Segmentectomy
6.3.3. Wedge Resection
6.3.4. Pneumonectomy
6.4. Market Attractiveness By Procedure
7. Global Lung Cancer Surgery Market Analysis and Forecasts, By Approach
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Approach, 2017 - 2031
7.3.1. Thoracotomy
7.3.2. Minimally Invasive Surgery
7.4. Market Attractiveness By Approach
8. Global Lung Cancer Surgery Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017 - 2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness By End-user
9. Global Lung Cancer Surgery Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Lung Cancer Surgery Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Procedure, 2017 - 2031
10.2.1. Lobectomy
10.2.2. Segmentectomy
10.2.3. Wedge Resection
10.2.4. Pneumonectomy
10.3. Market Value Forecast By Approach, 2017 - 2031
10.3.1. Thoracotomy
10.3.2. Minimally Invasive Surgery
10.4. Market Value Forecast By End-user, 2017 - 2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast By Country, 2017 - 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Procedure
10.6.2. By Approach
10.6.3. By End-user
10.6.4. By Country
11. Europe Lung Cancer Surgery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Procedure, 2017 - 2031
11.2.1. Lobectomy
11.2.2. Segmentectomy
11.2.3. Wedge Resection
11.2.4. Pneumonectomy
11.3. Market Value Forecast By Approach, 2017 - 2031
11.3.1. Thoracotomy
11.3.2. Minimally Invasive Surgery
11.4. Market Value Forecast By End-user, 2017 - 2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast By Country, 2017 - 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Procedure
11.6.2. By Approach
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Lung Cancer Surgery Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Procedure, 2017 - 2031
12.2.1. Lobectomy
12.2.2. Segmentectomy
12.2.3. Wedge Resection
12.2.4. Pneumonectomy
12.3. Market Value Forecast By Approach, 2017 - 2031
12.3.1. Thoracotomy
12.3.2. Minimally Invasive Surgery
12.4. Market Value Forecast By End-user, 2017 - 2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast By Country, 2017 - 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Resr of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Procedure
12.6.2. By Approach
12.6.3. By End-user
12.6.4. By Country
13. Latin America Lung Cancer Surgery Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Procedure, 2017 - 2031
13.2.1. Lobectomy
13.2.2. Segmentectomy
13.2.3. Wedge Resection
13.2.4. Pneumonectomy
13.3. Market Value Forecast By Approach, 2017 - 2031
13.3.1. Thoracotomy
13.3.2. Minimally Invasive Surgery
13.4. Market Value Forecast By End-user, 2017 - 2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast By Country, 2017 - 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Procedure
13.6.2. By Approach
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Lung Cancer Surgery Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Procedure, 2017 - 2031
14.2.1. Lobectomy
14.2.2. Segmentectomy
14.2.3. Wedge Resection
14.2.4. Pneumonectomy
14.3. Market Value Forecast By Approach, 2017 - 2031
14.3.1. Thoracotomy
14.3.2. Minimally Invasive Surgery
14.4. Market Value Forecast By End-user, 2017 - 2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast By Country, 2017 - 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Procedure
14.6.2. By Approach
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2022)
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Siemens Healthineers
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Accuray Incorporated
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. KARL STORZ
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Olympus Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Intuitive Surgical
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Ethicon (Johnson & Johnson Services, Inc.)
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Other Prominent Players
List of Tables
Table 01: Global Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017‒2031
Table 02: Global Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Approach, 2017–2031
Table 03: Global Lung Cancer Surgery Market Value (US$ Mn) Forecast, By End-user, 2017–2031
Table 04: Global Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017‒2031
Table 07: North America Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Approach, 2017–2031
Table 08: North America Lung Cancer Surgery Market Value (US$ Mn) Forecast, By End-user, 2017–2031
Table 09: Europe Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 10: Europe Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017‒2031
Table 11: Europe Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Approach, 2017–2031
Table 12: Europe Lung Cancer Surgery Market Value (US$ Mn) Forecast, By End-user, 2017–2031
Table 13: Asia Pacific Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017‒2031
Table 15: Asia Pacific Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Approach, 2017–2031
Table 16: Asia Pacific Lung Cancer Surgery Market Value (US$ Mn) Forecast, By End-user, 2017–2031
Table 17: Latin America Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017‒2031
Table 19: Latin America Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Approach, 2017–2031
Table 20: Latin America Lung Cancer Surgery Market Value (US$ Mn) Forecast, By End-user, 2017–2031
Table 21: Middle East & Africa Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Procedure, 2017‒2031
Table 22: Middle East & Africa Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Approach, 2017–2031
Table 23: Middle East & Africa Lung Cancer Surgery Market Value (US$ Mn) Forecast, By End-user, 2017–2031
Table 24: Middle East & Africa Lung Cancer Surgery Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
Figure 01: Global Lung Cancer Surgery Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Lung Cancer Surgery Market Value Share, by Procedure, 2022
Figure 03: Lung Cancer Surgery Market Value Share, by Approach, 2022
Figure 04: Lung Cancer Surgery Market Value Share, By End-user, 2022
Figure 05: Global Lung Cancer Surgery Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 06: Global Lung Cancer Surgery Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 07: Global Lung Cancer Surgery Market Value (US$ Mn), by Lobectomy, 2017‒2031
Figure 08: Global Lung Cancer Surgery Market Value (US$ Mn), by Segmentectomy, 2017‒2031
Figure 09: Global Lung Cancer Surgery Market Value (US$ Mn), by Wedge Resection, 2017‒2031
Figure 10: Global Lung Cancer Surgery Market Value (US$ Mn), by Pneumonectomy, 2017‒2031
Figure 11: Global Lung Cancer Surgery Market Value Share Analysis, by Approach, 2022 and 2031
Figure 12: Global Lung Cancer Surgery Market Attractiveness Analysis, by Approach, 2023–2031
Figure 13: Global Lung Cancer Surgery Market Revenue (US$ Mn), by Thoracotomy, 2017–2031
Figure 14: Global Lung Cancer Surgery Market Revenue (US$ Mn), by Minimally Invasive Surgery 2017–2031
Figure 15: Global Lung Cancer Surgery Market Value Share Analysis, By End-user, 2022 and 2031
Figure 16: Global Lung Cancer Surgery Market Attractiveness Analysis, By End-user, 2023–2031
Figure 17: Global Lung Cancer Surgery Market Revenue (US$ Mn), by Hospitals 2017–2031
Figure 18: Global Lung Cancer Surgery Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 19: Global Lung Cancer Surgery Market Revenue (US$ Mn), by Others, 2017–2031
Figure 20: Global Lung Cancer Surgery Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Lung Cancer Surgery Market Attractiveness Analysis, by Region, 2023–2031
Figure 22: North America Lung Cancer Surgery Market Value (US$ Mn) Forecast, 2017–2031
Figure 23: North America Lung Cancer Surgery Market Value Share Analysis, by Country, 2022 and 2031
Figure 24: North America Lung Cancer Surgery Market Attractiveness Analysis, by Country, 2023–2031
Figure 25: North America Lung Cancer Surgery Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 26: North America Lung Cancer Surgery Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 27: North America Lung Cancer Surgery Market Value Share Analysis, by Approach, 2022 and 2031
Figure 28: North America Lung Cancer Surgery Market Attractiveness Analysis, by Approach, 2023–2031
Figure 29: North America Lung Cancer Surgery Market Value Share Analysis, By End-user, 2022 and 2031
Figure 30: North America Lung Cancer Surgery Market Attractiveness Analysis, By End-user, 2023–2031
Figure 31: Europe Lung Cancer Surgery Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Europe Lung Cancer Surgery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 33: Europe Lung Cancer Surgery Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 34: Europe Lung Cancer Surgery Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 35: Europe Lung Cancer Surgery Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 36: Europe Lung Cancer Surgery Market Value Share Analysis, by Approach, 2022 and 2031
Figure 37: Europe Lung Cancer Surgery Market Attractiveness Analysis, by Approach, 2023–2031
Figure 38: Europe Lung Cancer Surgery Market Value Share Analysis, By End-user, 2022 and 2031
Figure 39: Europe Lung Cancer Surgery Market Attractiveness Analysis, By End-user, 2023–2031
Figure 40: Asia Pacific Lung Cancer Surgery Market Value (US$ Mn) Forecast, 2017–2031
Figure 41: Asia Pacific Lung Cancer Surgery Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Asia Pacific Lung Cancer Surgery Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 43: Asia Pacific Lung Cancer Surgery Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 44: Asia Pacific Lung Cancer Surgery Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 45: Asia Pacific Lung Cancer Surgery Market Value Share Analysis, by Approach, 2022 and 2031
Figure 46: Asia Pacific Lung Cancer Surgery Market Attractiveness Analysis, by Approach, 2023–2031
Figure 47: Asia Pacific Lung Cancer Surgery Market Value Share Analysis, By End-user, 2022 and 2031
Figure 48: Asia Pacific Lung Cancer Surgery Market Attractiveness Analysis, By End-user, 2023–2031
Figure 49: Latin America Lung Cancer Surgery Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Latin America Lung Cancer Surgery Market Value Share Analysis, by Country/Sub-Region, 2022 and 2031
Figure 51: Latin America Lung Cancer Surgery Market Attractiveness Analysis, by Country/Sub-Region, 2023-2031
Figure 52: Latin America Lung Cancer Surgery Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 53: Latin America Lung Cancer Surgery Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 54: Latin America Lung Cancer Surgery Market Value Share Analysis, by Approach, 2022 and 2031
Figure 55: Latin America Lung Cancer Surgery Market Attractiveness Analysis, by Approach, 2023–2031
Figure 56: Latin America Lung Cancer Surgery Market Value Share Analysis, By End-user, 2022 and 2031
Figure 57: Latin America Lung Cancer Surgery Market Attractiveness Analysis, By End-user, 2023–2031
Figure 58: Middle East & Africa Lung Cancer Surgery Market Value (US$ Mn) Forecast, 2017–2031
Figure 59: Middle East & Africa Lung Cancer Surgery Market Value Share Analysis, by Country/Sub-Region, 2022 and 2031
Figure 60: Middle East & Africa Lung Cancer Surgery Market Attractiveness Analysis, by Country/Sub-Region, 2023-2031
Figure 61: Middle East & Africa Lung Cancer Surgery Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 62: Middle East & Africa Lung Cancer Surgery Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 63: Middle East & Africa Lung Cancer Surgery Market Value Share Analysis, by Approach, 2022 and 2031
Figure 64: Middle East & Africa Lung Cancer Surgery Market Attractiveness Analysis, by Approach, 2023–2031
Figure 65: Middle East & Africa Lung Cancer Surgery Market Value Share Analysis, By End-user, 2022 and 2031
Figure 66: Middle East & Africa Lung Cancer Surgery Market Attractiveness Analysis, By End-user, 2023–2031
Figure 67: Company Share Analysis, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Lung Cancer Surgery Market
*86 figures and 60 tables includes